ABSTRACT

Elevated intraocular pressure (IOP) is a major risk factor for optic nerve damage and loss of visual field in patients with glaucoma and ocular hypertension.1 In addition to b-adrenergic antagonists, carbonic anhydrase inhibitors, and cholinergic agonists, prostaglandin derivatives are a proven therapeutic option to reduce IOP.